Nanosuspension Technologies for Delivery of Poorly Soluble Drugs

被引:65
|
作者
Yadollahi, Roya [1 ]
Vasilev, Krasimir [1 ,2 ]
Simovic, Spomenka [3 ]
机构
[1] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia
[2] Univ S Australia, Sch Engn, Adelaide, SA 5095, Australia
[3] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5095, Australia
关键词
BIOPHARMACEUTICS CLASSIFICATION-SYSTEM; HIGH-PRESSURE HOMOGENIZATION; IN-VITRO; TISSUE DISTRIBUTION; MUCOADHESIVE NANOSUSPENSIONS; PHARMACOKINETIC EVALUATION; NANOCRYSTAL TECHNOLOGY; ORAL BIOAVAILABILITY; CONTROLLED-RELEASE; DISSOLUTION RATE;
D O I
10.1155/2015/216375
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Poor aqueous solubility of some drug molecules is a major problem in drug formulation. Drug nanosuspensions emerged as one solution to delivering such hydrophobic drugs. Scaling down to nanoparticles enhances drug aqueous solubility and bioavailability by increasing drug surface area that comes into contact with biological media. Nanosuspensions that have attracted particular attention are those sterically stabilised by steric polymers such as polyethylene glycol (PEG) with a typical size range of 10-100 nm. These nanoparticles are capable of accumulating in targeted areas such as cancer tissues and infarct zones with minimal damage to healthy tissues. Nanosuspensions are often prepared by commercially available methods such as high pressure homogenization, media milling, emulsification, and melt emulsification. Solidification and surface modification methods are post-processing techniques used to add particular properties for advanced therapies. In this review, we firstly describe preparation methods for nanosuspensions. Secondly, we highlight typical characterization techniques. Finally, we describe several practical application of applications for drug delivery design and different administration routes such as parenteral, pulmonary, oral, and ocular.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Drug delivery strategies for poorly water-soluble drugs
    Fahr, Alfred
    Liu, Xiangli
    EXPERT OPINION ON DRUG DELIVERY, 2007, 4 (04) : 403 - 416
  • [22] Nanocrystals for the parenteral delivery of poorly water-soluble drugs
    Sun, Bo
    Yeo, Yoon
    CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE, 2012, 16 (06): : 295 - 301
  • [23] State of the art of nanocrystals technology for delivery of poorly soluble drugs
    Zhou, Yuqi
    Du, Juan
    Wang, Lulu
    Wang, Yancai
    JOURNAL OF NANOPARTICLE RESEARCH, 2016, 18 (09)
  • [24] SmartFilm Tablets for Improved Oral Delivery of Poorly Soluble Drugs
    Abdelkader, Ayat
    Preis, Eduard
    Keck, Cornelia M.
    PHARMACEUTICS, 2022, 14 (09)
  • [25] Microgels and Nanogels for the Delivery of Poorly Water-Soluble Drugs
    Dave, Ridhdhi
    Randhawa, Gurpreet
    Kim, Daeun
    Simpson, Madeline
    Hoare, Todd
    MOLECULAR PHARMACEUTICS, 2022, 19 (06) : 1704 - 1721
  • [26] State of the art of nanocrystals technology for delivery of poorly soluble drugs
    Yuqi Zhou
    Juan Du
    Lulu Wang
    Yancai Wang
    Journal of Nanoparticle Research, 2016, 18
  • [27] Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs
    Pu, Xiaohui
    Sun, Jin
    Li, Mo
    He, Zhonggui
    CURRENT NANOSCIENCE, 2009, 5 (04) : 417 - 427
  • [28] Poorly soluble drugs
    Siepmann, Juergen
    Rades, Thomas
    Muellertz, Anette
    Loftsson, Thorsteinn
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 577
  • [29] Developing an in situ nanosuspension: A novel approach towards the efficient administration of poorly soluble drugs at the anterior eye
    Luschmann, Christoph
    Tessmar, Joerg
    Schoeberl, Simon
    Strauss, Olaf
    Framme, Carsten
    Luschmann, Karl
    Goepferich, Achim
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 (3-4) : 385 - 392
  • [30] Effects of Nanosuspension Formulations on Transport, Pharmacokinetics, In Vivo Targeting and Efficacy for Poorly Water-soluble Drugs
    Wang, Yancai
    Miao, Xiaoqing
    Sun, Lin
    Song, Ju
    Bi, Chao
    Yang, Xiao
    Zheng, Ying
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (03) : 454 - 473